A Six-Week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Subjects with Obstructive Sleep Apnea (OSA)

  • STATUS
    Recruiting
Send
Updated on 19 February 2024

Summary

Medication trial for the treatment of excessive sleepiness in adult subjects with treated or untreated obstructive sleep apnea (OSA).

Description

This trial is testing a drug for adult subjects with sleep apnea to see if it can help treat excessive sleepiness and improve patients’ ability to stay awake. We are looking for subjects who have been diagnosed with sleep apnea and are either currently being treated for sleep apnea, or have tried treatment in the past (either with CPAP, oral appliance, or surgery). Subjects do not need to be currently treated for sleep apnea. Subjects will undergo overnight sleep studies and daytime sleepiness tests to determine level of sleepiness. If subjects qualify for the study, they will be given the study medication and will take it for up to 6 weeks. Subjects will be asked to come in for periodic monitoring visits to assess changes in sleepiness (including overnight sleep studies and daytime sleepiness tests). All tests are covered by the sponsor (no tests are billed to insurance) and compensation is provided for time and travel for the study.

Details
Condition Apnea, Sleep Apnea Syndromes, Obstructive sleep apnea, Obstructive Sleep Apnea (OSA)
Age 18years - 100years
Clinical Study IdentifierTX1038
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.